Why HHS Is Moving Syphilis Testing Into Emergency Departments

On August 12, 2026, the U.S. Department of Health and Human Services announced a $4 million initiative to expand rapid, point-of-care syphilis testing, with an explicit focus on reaching women in emergency departments and other settings beyond traditional prenatal care. HHS Secretary Robert F. Kennedy Jr. framed the move as an effort to detect infections earlier and begin treatment faster, particularly for mothers and babies who currently fall through the gaps in routine care.

The urgency comes from a sustained public health failure: congenital syphilis cases have risen for 12 consecutive years. Nearly 4,000 cases were reported in 2024, an increase of almost 700% over the past decade. In 2023 alone, congenital syphilis contributed to 279 stillbirths and infant deaths. HHS estimates that 83% of those cases could have been prevented with timely testing and treatment.

The testing gap is concentrated among women who do not receive regular prenatal care in traditional settings. According to the department, more than 40% of pregnant women who delivered a baby with congenital syphilis in 2023 did not receive a syphilis test in time for adequate treatment before delivery. Point-of-care tests can return results quickly enough for providers to begin treatment during the same visit, rather than waiting for standard laboratory confirmation.

The funding will flow through the Centers for Disease Control and Prevention's Division of STD Prevention. About $3.25 million will go to recipients of the existing PS19-1901 cooperative agreement in high-burden jurisdictions from August 2026 through February 2027. The remaining money will support national technical assistance and implementation partners. Target settings include emergency departments, maternal and child health programs, correctional intake sites, and substance use treatment programs.

Advertisement

What the $4 Million Buys — and What It Does Not Solve

A Twelve-Year Rise That Standard Prenatal Care Has Not Stopped

The central problem is not a lack of treatment, but missed opportunities to test. The 40% figure for pregnant women who were not tested in time is the clearest indicator. Women who are disconnected from regular prenatal visits remain outside the standard screening pathway, which means identifying them requires moving testing into places where they do seek care. That logic is behind the emergency department focus: for many patients, the ED is the only consistent point of contact with the health system.

Inside the PS19-1901 Funding Route

The initiative is not a new standalone program. HHS is adding roughly $3.25 million in supplemental awards to an existing CDC cooperative agreement for health departments. Using that structure should allow money to move faster than designing a new grant mechanism, but the funding window is short: August 2026 through February 2027. That suggests the administration wants rapid deployment in a high-burden set of jurisdictions, not a long-term infrastructure build at this stage. The announcement does not identify the specific jurisdictions or say what happens after February 2027.

Emergency Departments and Correctional Intake as the Real Front Line

The choice of settings matters more than the dollar amount. Emergency departments, correctional intake sites and substance use treatment programs reach populations that are disproportionately likely to have missed prenatal screening. However, integrating point-of-care syphilis testing into those environments is not automatic. It requires staff training, supply chain management, and clear protocols for linking positive patients to treatment and follow-up. The national technical assistance funding is meant to address some of those implementation barriers, but the announcement provides no data yet on how many sites will participate or how many additional tests will be administered.

Next Steps for Health Departments and Frontline Providers

  • Health departments receiving PS19-1901 supplemental funding should use the August 2026 start date to target emergency departments, correctional intake sites and substance use programs in their highest-burden areas.
  • Frontline providers in those settings can use rapid point-of-care results to begin treatment for pregnant patients during the same visit, avoiding the delay associated with traditional lab testing.
  • Since the announced funding window ends in February 2027, health departments should use it to build referral links to maternal and child health programs and document outcomes from same-visit treatment.
  • Maternal and child health staff should coordinate with local STD programs; national partners funded under the initiative are available for implementation support, but no additional funding beyond February 2027 is specified in the announcement.